Skip to content

Study · In vitro (cells) · rat · 2023

9 results

Kisspeptin (Kp-10) inhibits in vitro osteogenic differentiation of multipotent mesenchymal stromal cells extracted from the bone marrow of adult rats.

Guimarães LB, Machado DPD, Carvalho Versiani Caldeira BF, Vieira LTM, Santos GA, Araújo FR, Machado LT, Gomes DA, Ocarino NM, Serakides R, Reis AMS

Acta histochemica8 Nov 2023Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study9

9 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Efficacy outcome

    In rat bone marrow MSCs, Kp-10 reduced in vitro osteogenic differentiation.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 reduced the change of stem cells into bone-forming cells.

    Outcome
    DecreaseOsteogenic differentiation of MSCs
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    It was observed that MSCs expressed GPR54 receptor to which Kp-10 binds during osteogenic differentiation, promoting a negative effect on osteogenic differentiation.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  2. 02LabIn vitro (cells)Mechanism

    In rat bone marrow MSCs, the GPR54 receptor to which Kp-10 binds was expressed during osteogenic differentiation.

    In plain wordsIn rat cells grown in a dish, the receptor that kisspeptin‑10 binds to was present during bone-cell differentiation.

    Outcome
    Not applicableGPR54 receptor expression in MSCs
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Receptor activity and mechanism · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    It was observed that MSCs expressed GPR54 receptor to which Kp-10 binds during osteogenic differentiation, promoting a negative effect on osteogenic differentiation.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  3. 03LabIn vitro (cells)Efficacy outcome

    In rat bone marrow MSCs, Kp-10 decreased alkaline phosphatase activity at all concentrations in a concentration-dependent manner.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered an enzyme marker of bone formation, more at higher amounts.

    Outcome
    DecreaseAlkaline phosphatase activity
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  4. 04LabIn vitro (cells)Efficacy outcome

    In rat bone marrow MSCs, Kp-10 decreased collagen synthesis at all concentrations in a concentration-dependent manner.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered collagen production, more at higher amounts.

    Outcome
    DecreaseCollagen synthesis
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  5. 05LabIn vitro (cells)Efficacy outcome

    In rat bone marrow MSCs, Kp-10 decreased mineralized nodules at all concentrations in a concentration-dependent manner.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered the number of mineral deposits, more at higher amounts.

    Outcome
    DecreaseMineralized nodules
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  6. 06LabIn vitro (cells)Mechanism

    In rat bone marrow MSCs, Kp-10 decreased expression of type I collagen gene transcripts.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered the activity of the type I collagen gene.

    Outcome
    DecreaseType I collagen gene transcripts
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  7. 07LabIn vitro (cells)Mechanism

    In rat bone marrow MSCs, Kp-10 decreased expression of osteocalcin gene transcripts.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered the activity of the osteocalcin gene.

    Outcome
    DecreaseOsteocalcin gene transcripts
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  8. 08LabIn vitro (cells)Mechanism

    In rat bone marrow MSCs, Kp-10 decreased expression of osteopontin gene transcripts.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered the activity of the osteopontin gene.

    Outcome
    DecreaseOsteopontin gene transcripts
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.
  9. 09LabIn vitro (cells)Mechanism

    In rat bone marrow MSCs, Kp-10 decreased expression of Runx-2 gene transcripts.

    In plain wordsIn rat cells grown in a dish, kisspeptin‑10 lowered the activity of the Runx-2 gene.

    Outcome
    DecreaseRunx-2 gene transcripts
    Study

    ratn: not reported in source

    bone marrow mesenchymal stromal cells from adult Wistar rats
    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    0.01, 0.05 and 0.1 µg/mL · in vitroAs given in this study (rat).

    Source sentences

    Summary
    This effect was observed at all the Kp-10 concentrations in a concentration-dependent manner, characterized by a decrease in the activity of alkaline phosphatase, collagen synthesis, mineralized nodules, and decreased expression of gene transcripts for type I collagen, osteocalcin, osteopontin, and Runx-2.
    1 context sentence
    Summary · context
    Four experimental groups were established in vitro: a control and Kp-10 at concentrations of 0.01, 0.05 and, 0.1 µg/mL.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.